Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
EGFR mutation + EGFR T790M
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1956
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
(2)
News
Trials
Search handles
@StephenVLiu
@VamsiVelcheti
@jsoriamd
Search handles
@StephenVLiu
@VamsiVelcheti
@jsoriamd
Filter by
Latest
over3years
#OncoAlert Online @CCR_AACR is the phase I study of osimertinib and ramucirumab in #EGFR T790M mutant NSCLC by @HelenaYu923 @Piuchagarrido @dplanchard #LCSM https://t.co/apX7bYCTKH (@StephenVLiu)
over 3 years ago
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR T790M • EGFR mutation + EGFR T790M
|
Tagrisso (osimertinib)
over3years
The 2nd Annals of Oncology podcast is out on @SoundCloud ! https://t.co/GFJbzv2yvt Listen to Pr Mok @TonyMok9 discussing the OS analysis of AURA3 investigating Osimertinib in NSCLC with EGFR T790M mutations. You can find the manuscript here: https://t.co/kim3N4SF3T #LCSM (@Annals_Oncology)
over 3 years ago
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR T790M • EGFR mutation + EGFR T790M
|
Tagrisso (osimertinib)
over3years
Promising perspectives for EGFR mutant #lcsm #ESMO20 with 4th generation EGFR TKI that can block triple mutant EGFR/T790M/C797S (@jsoriamd)
over 3 years ago
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR T790M • EGFR C797S • EGFR mutation + EGFR T790M • EGFR mutation + EGFR T790M + EGFR C797S
over3years
1259O - A randomized phase II study of osimertinib with or without bevacizumab in advanced lung adenocarcinoma patients with EGFR T790M mutation (West Japan Oncology Group 8715L) (@VamsiVelcheti)
over 3 years ago
Clinical • P2 data
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR T790M • EGFR mutation + EGFR T790M
|
Avastin (bevacizumab) • Tagrisso (osimertinib)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login